Neoplasm Metastasis: all 3,564 studies
Page 20 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesCompletedNCT04672434Phase 1
- A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid TumorsCompletedNCT04670679Phase 1
- Splenic Hilar Nodes in Splenic Flexure CancerStatus unknownNCT04666883
- LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT04666688Phase 1/2
- SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung CancerWithdrawnNCT04650490Phase 2
- Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial MalignanciesWithdrawnNCT04648826Phase 1/2
- Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid TumorCompletedNCT04648254Phase 1
- FS120 Phase 1/1b Study in Patients With Advanced MalignanciesActive, not recruitingNCT04648202Phase 1
- A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain MetastasesStatus unknownNCT04643847Phase 2
- Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesCompletedNCT04641871Phase 1
- A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer CenterStatus unknownNCT04641676Not applicable
- Prediction Model for Lateral Lymph Node MetastasisStatus unknownNCT04635488
- Ablation and Cementoplasty for Painful Bone LesionsStatus unknownNCT04635137Not applicable
- Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid TumorsCompletedNCT04630522Phase 1
- Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain MetastasesStatus unknownNCT04626206
- Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung TumorsCompletedNCT04619472Not applicable
- A Study of EMB-02 in Participants With Advanced Solid TumorsTerminatedNCT04618393Phase 1/2
- Use of Chinese Herbal Formula Shu Yu Wan in Lung Cancer PatientsWithdrawnNCT04615884Not applicable
- ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic CancerWithdrawnNCT04602117Phase 1
- Personalised Disease Monitoring in Metastatic Breast CancerActive, not recruitingNCT04597580
- MAnagement of METastatic Disease in Campania (MAMETIC)CompletedNCT04595032
- Long Term Special Drug Use-results Surveillance for Mayzent in SPMS PatientsCompletedNCT04593927
- ICF in Secondary Prevention of Cardiovascular DiseaseCompletedNCT04590287
- Secondary Lymphedema Due to Human Adjuvant DiseaseCompletedNCT04588493
- Is the Dynamic of the Pelvic Bone Altered After a Total Hip Replacement ?TerminatedNCT04587440Not applicable
- Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19Status unknownNCT04586114
- Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain MetastasesStatus unknownNCT04582968Phase 1/2
- Gastric Cancer Liver Metastasis Cohort of ChinaStatus unknownNCT04574245
- CTC in Lung Caner Patients With Bone MetastasesStatus unknownNCT04568291Not applicable
- Survivorship Study of Cancer Patients Who Received Cranial Radiation TherapyTerminatedNCT04567251
- To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid TumorsStatus unknownNCT04550949Phase 3
- Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsActive, not recruitingNCT04550494Phase 2
- Telerehabilitation in Oncology PatientsCompletedNCT04547634Not applicable
- Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DICCompletedNCT04547153Phase 2
- A Phase I/II Study of XZP-3287 in Metastasis Solid TumorsActive, not recruitingNCT04539496Phase 1/2
- Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of PembrolizumabWithdrawnNCT04536922Phase 2
- Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal CancerCompletedNCT04534218Phase 2
- A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Active, not recruitingNCT04534205Phase 2/3
- ARREST - A Phase I Study of SABR for Poly-metastatic DiseaseCompletedNCT04530513Not applicable
- 68Ga-BNU-PSMA PET/CT in Patients With Various Types of CancerStatus unknownNCT04525612Early Phase 1
- Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver MetastasesStatus unknownNCT04525326Phase 3
- The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM PatientsStatus unknownNCT04525313
- Preemptive and Precise Intervention for CKD-SHPTStatus unknownNCT04523974
- Chemotherapy for Resectable Colorectal Liver MetastasesCompletedNCT04513457
- A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)Status unknownNCT04513431Early Phase 1
- TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain MetastasesWithdrawnNCT04512261Phase 1/2
- Cetuximab Re-challenge for Colorectal Cancer Liver MetastasisStatus unknownNCT04509635Phase 3
- Role of EUS in Detection of Liver MetastasisCompletedNCT04509492
- Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients With Lung Tumors in Close Proximity to the Chest WallCompletedNCT04507828Not applicable
- Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLCCompletedNCT04507217Phase 2
- 99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal CarcinomaStatus unknownNCT04504565Not applicable
- CT-DSA Evaluation of Embolization in Debulking Spinal SurgeryCompletedNCT04497051
- Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy AdultsStatus unknownNCT04494373Phase 1
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersActive, not recruitingNCT04485013Phase 1
- IOPTH Usefulness for Predicting Successful Surgery in Secondary HyperparathyroidismCompletedNCT04484116
- Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor MalignanciesTerminatedNCT04465487Phase 1
- Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnNCT04464967Phase 1/2
- Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.CompletedNCT04463771Phase 2
- Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma MetastasesCompletedNCT04463368Phase 1
- Study of PF-07265807 in Participants With Metastatic Solid Tumors.TerminatedNCT04458259Phase 1
- A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)Status unknownNCT04457869Phase 2
- Proton Beam Therapy for Unresectable Liver MetastasisCompletedNCT04456621Not applicable
- Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRTCompletedNCT04452084Phase 2
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C MutationActive, not recruitingNCT04449874Phase 1
- Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)Active, not recruitingNCT04447651
- A Study to Evaluate ICP-022 in Patients With R/R PCNSL and SCNSLStatus unknownNCT04438044Phase 2
- Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)Status unknownNCT04435067
- Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SCompletedNCT04430842Phase 1
- Validity of Fluorescence-Based Devices Versus Visual-Tactile Method in Detection of Secondary Caries Around Resin Composite Restorations: Invivo Diagnostic Accuracy StudyStatus unknownNCT04426604Not applicable
- Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung CancerStatus unknownNCT04425681Phase 2
- Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During ThyroidectomyStatus unknownNCT04424485Not applicable
- A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）WithdrawnNCT04420130Not applicable
- A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT04419532Phase 1
- To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency AblationStatus unknownNCT04417010
- X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain MetastasesStatus unknownNCT04415320Phase 2
- SOFT- Stereotactic Ablative Radiotherapy of Infra-diaphragmatic Soft Tissue MetastasesStatus unknownNCT04407897Not applicable
- Irreversible Electroporation of Unresectable Liver TumorsWithdrawnNCT04404647Not applicable
- Systemic Chemotherapy Plus PD-1 for Metastasis ICCWithdrawnNCT04398927Phase 2
- GM1 Prophylaxis for WBRT Related Cognitive DysfunctionTerminatedNCT04395339Phase 3
- A Study to Investigate the Possible Causes of Secondary Effects During Use of Peripheral Midline Type Catheter in Patients Hospitalized in Different Care SettingsCompletedNCT04391205
- Optimizing Y90 Therapy for Radiation LobectomyActive, not recruitingNCT04390724
- DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell CancersActive, not recruitingNCT04388852Phase 1
- NCI COVID-19 in Cancer Patients, NCCAPS StudyActive, not recruitingNCT04387656
- Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral AugmentationActive, not recruitingNCT04375891Not applicable
- Testing the Safety of CB-5339 in Patients With CancerWithdrawnNCT04372641Phase 1
- Microwave Ablation of Primary and Secondary Lung MalignanciesStatus unknownNCT04369872Phase 1/2
- Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)Active, not recruitingNCT04365374Phase 3
- Evaluation of the Best Treatment in Terms of Quality of Life for Patients Having a Brain MetastasisStatus unknownNCT04358666Not applicable
- Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal MetastasisStatus unknownNCT04356222Phase 4
- Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal MetastasisStatus unknownNCT04356118Phase 4
- Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsTerminatedNCT04348916Phase 1
- Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLCCompletedNCT04345146Phase 2
- Salvage Surgery for Patients With Metastatic GIST With RegoCompletedNCT04343456
- An Open Label, Multicenter, Phase II Study of Dacomitinib for EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) With Brain MetastasesStatus unknownNCT04339829Phase 2
- Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC PatientsCompletedNCT04338867Phase 2
- Palbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in ChinaStatus unknownNCT04334330Phase 2
- Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 InfectionCompletedNCT04333914Phase 2
- Informational Meetings for Planning and Coordinating TreatmentCompletedNCT04330833Not applicable
- Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)CompletedNCT04330664Phase 1
- Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast CancerStatus unknownNCT04322331